EDGAR Filing Documents for 0001104659-23-103527

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-23-103527

Filing Date

2023-09-25

Accepted

2023-09-25 16:27:57

Documents

Period of Report

2023-09-21

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	tm2326753-1_4.html	4
1	FORM 4	tm2326753-1_4.xml	4	6294
	Complete submission text file	0001104659-23-103527.txt		8208

Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121

Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100

Sorrento Therapeutics, Inc. (Reporting) CIK: 0000850261 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39852 | Film No.: 231276120
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303

Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310

Scilex Holding Co (Issuer) CIK: 0001820190 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)